Monteris Medical

Laser Interstitial Thermal Therapy Extends Survival in Glioblastoma When Tumor Ablation Exceeds 91% and Treatment Occurs Early

- A prospective multicenter analysis of 787 brain tumor patients found that the extent of tumor ablation and timing of laser interstitial thermal therapy (LITT) significantly influence survival outcomes. - Glioblastoma patients with at least 91% of their tumor cleared by the laser survived 2.1 years from diagnosis, compared with roughly 1.5 years for standard open surgical resection. - The minimally invasive NeuroBlate procedure requires only a single-stitch incision, limits average hospital stay to 32 hours, and preserves day-to-day quality of life. - Researchers suggest the laser therapy may be considered up front for newly diagnosed glioblastoma and earlier for small brain metastases rather than watchful waiting.